Quantitative assessment of tumor burden in multiple myeloma using MY-RADS from whole-body MRI: comparison with established prognostic biomarkers
Xing Xiong, Zhi Yan, Jia Wang, Yu He, Zhenyan Zhou, Dawei Li, Yue Xiong, Changyou Zhou · 2026
Read Quantitative assessment of tumor burden in multiple myeloma using MY-RADS from whole-body MRI: comparison with established prognostic biomarkers by Xing Xiong, Zhi Yan, Jia Wang, Yu He, Zhenyan Zhou, Dawei Li, Yue Xiong, Changyou Zhou (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13536559.txt.
Description
Xing Xiong and colleagues test in 2026 whole-body MRI scoring, called MY-RADS, to gauge tumour burden in multiple myeloma. Burden guides treatment and outlook, and standard markers need blood and marrow tests that are not always handy. Records covered 108 newly diagnosed patients with varied marrow patterns on scans.
Score value depended on pattern type. For focal and mixed patterns the total score separated stage and risk groups and tracked marrow plasma cell share well. For diffuse patterns, water and fat measures carried the signal instead, supporting pattern-aware use of the score.
Catalog record
| CREATOR | Xing Xiong, Zhi Yan, Jia Wang, Yu He, Zhenyan Zhou, Dawei Li, Yue Xiong, Changyou Zhou |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 37118 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |